Suppr超能文献

一种活性微弱的胸苷酸合成酶突变体(精氨酸126突变为谷氨酸)的晶体结构

Crystal structures of a marginally active thymidylate synthase mutant, Arg 126-->Glu.

作者信息

Strop P, Changchien L, Maley F, Montfort W R

机构信息

Department of Biochemistry, University of Arizona, Tucson 85721, USA.

出版信息

Protein Sci. 1997 Dec;6(12):2504-11. doi: 10.1002/pro.5560061203.

Abstract

Thymidylate synthase (TS) is a long-standing target for anticancer drugs and is of interest for its rich mechanistic features. The enzyme catalyzes the conversion of dUMP to dTMP using the co-enzyme methylenetetrahydrofolate, and is perhaps the best studied of enzymes that catalyze carbon-carbon bond formation. Arg 126 is found in all TSs but forms only 1 of 13 hydrogen bonds to dUMP during catalysis, and just one of seven to the phosphate group alone. Despite this, when Arg 126 of TS from Escherichia coli was changed to glutamate (R126E), the resulting protein had kcat reduced 2000-fold and Km reduced 600-fold. The crystal structure of R126E was determined under two conditions--in the absence of bound ligand (2.4 A resolution), and with dUMP and the antifolate CB3717 (2.2 A resolution). The first crystals, which did not contain dUMP despite its presence in the crystallization drop, displayed Glu 126 in a position to sterically and electrostatically interfere with binding of the dUMP phosphate. The second crystals contained both dUMP and CB3717 in the active site, but Glu 126 formed three hydrogen bonds to nearby residues (two through water) and was in a position that partially overlapped with the normal phosphate binding site, resulting in a approximately 1 A shift in the phosphate group. Interestingly, the protein displayed the typical ligand-induced conformational change, and the covalent bond to Cys 146 was present in one of the protein's two active sites.

摘要

胸苷酸合成酶(TS)长期以来一直是抗癌药物的靶点,因其丰富的作用机制而备受关注。该酶利用辅酶亚甲基四氢叶酸催化dUMP转化为dTMP,可能是催化碳-碳键形成的酶中研究得最为透彻的。精氨酸126存在于所有的TS中,但在催化过程中与dUMP仅形成13个氢键中的1个,单独与磷酸基团形成的氢键也仅占7个中的1个。尽管如此,当将大肠杆菌TS的精氨酸126替换为谷氨酸(R126E)时,所得蛋白质的kcat降低了2000倍,Km降低了600倍。在两种条件下测定了R126E的晶体结构——在没有结合配体的情况下(分辨率为2.4 Å),以及在有dUMP和抗叶酸药物CB3717的情况下(分辨率为2.2 Å)。第一批晶体尽管在结晶液滴中存在dUMP,但却不包含dUMP,其中的谷氨酸126在空间和静电方面会干扰dUMP磷酸基团的结合。第二批晶体在活性位点同时包含dUMP和CB3717,但谷氨酸126与附近残基形成了三个氢键(两个通过水),其位置与正常的磷酸结合位点部分重叠,导致磷酸基团发生了约1 Å的位移。有趣的是,该蛋白质呈现出典型的配体诱导构象变化,并且与半胱氨酸146的共价键存在于蛋白质的两个活性位点之一中。

相似文献

引用本文的文献

本文引用的文献

1
Raster3D Version 2.0. A program for photorealistic molecular graphics.光栅3D版本2.0。一个用于逼真分子图形的程序。
Acta Crystallogr D Biol Crystallogr. 1994 Nov 1;50(Pt 6):869-73. doi: 10.1107/S0907444994006396.
8
The catalytic mechanism and structure of thymidylate synthase.胸苷酸合成酶的催化机制与结构
Annu Rev Biochem. 1995;64:721-62. doi: 10.1146/annurev.bi.64.070195.003445.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验